Enteris Biopharma, Inc.

Get Full Access

Description

  • Enteris BioPharma is a privately held, biotechnology company offering innovative formulation solutions built around its proprietary drug delivery technologies.Since its founding in 2013, Enteris has advanced multiple internal and external programs leveraging its Peptelligence platform. The technology has been developed and proven effective over the last decade to enable the safe delivery of peptide-based therapeutics and other molecules with low oral bioavailability.Currently, Enteris BioPharmas internal product pipeline consists of Ovarest (oral leuprolide tablet), a Phase 2a-ready oral peptide for endometriosis, and Tobrate (oral tobramycin tablet) for the treatment of uncomplicated urinary tract infection (uUTI). External market analyses demonstrate projected annual U.S. revenue potential for these two products in excess of $1 billion in aggregate.Additionally, Enteris BioPharmas oral peptide delivery technology is the subject of several active external development programs, the most advanced of which include Tarsa Therapeutics TBRIA, an oral calcitonin for patients with postmenopausal osteoporosis, and an oral formulation of Cara Therapeutics CR845, a potent peripheral kappa opioid receptor agonist which demonstrated positive safety, tolerability, PK and efficacy data in a recently completed Phase 2a clinical trial in chronic pain patients with osteoarthritis of the knee or hip.
  • location

    Headquarters:83 Fulton Street , Boonton, New Jersey, United States

    More
  • Enteris Biopharma, Inc. phone

    Phone Number: +1 973-453-3530

  • Enteris Biopharma, Inc. website

    Website: https://www.enterisbiopharma.com

  • Enteris Biopharma, Inc. employees

    Employees:22

  • Enteris Biopharma, Inc. revenue

    Revenue:$10 - 50M

  • Enteris Biopharma, Inc. legal name

    Legal Name:Enteris Biopharma, Inc.

  • Enteris Biopharma, Inc.'s Social Media

    Enteris Biopharma, Inc. linkedin Enteris Biopharma, Inc. twitter
  • done Is this data correct?
  • |  NAICS Code: 446110  |

    Show More
Person level website identification

Director, Product Development And Quality Control for Enteris Biopharma, Inc.

Tom Daggs

Director, Product Development And Quality Control

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Tom Daggs

Director, Product Development And Quality Control

John Vrettos

Director, Formulation Development

Amy Sturmer-Margulis

Director Bioanalytical Development

Andy Rasums

Director Of Quality Assurance

Kalpana Ramakrishnan

Manager, Business Development

Frequently Asked Questions regarding Enteris Biopharma, Inc.

  • Where are Enteris Biopharma, Inc.'s Headquarters?

    Enteris Biopharma, Inc.'s Headquarters are in 83 Fulton Street ,Boonton,New Jersey,United States

  • What is Enteris Biopharma, Inc.'s phone number?

    Enteris Biopharma, Inc.'s phone number is +1 973-453-3530

  • What is Enteris Biopharma, Inc.'s official website?

    Enteris Biopharma, Inc.'s official website is https://www.enterisbiopharma.com

  • What is Enteris Biopharma, Inc.'s Revenue?

    Enteris Biopharma, Inc.'s revenue is $10 - 50M

  • What is Enteris Biopharma, Inc.'s NAICS code?

    Enteris Biopharma, Inc.'s NAICS code is 446110

  • How many employees are working in Enteris Biopharma, Inc.

    Enteris Biopharma, Inc. has 22 employees

  • What is Enteris Biopharma, Inc.'s Industry?

    Enteris Biopharma, Inc. is in the industry of Biotechnology

  • Who is Enteris Biopharma, Inc.'s Director, Product Development And Quality Control?

    Enteris Biopharma, Inc.'s Director, Product Development And Quality Control is Tom Daggs

Company Directory